vs
Side-by-side financial comparison of LTC PROPERTIES INC (LTC) and Twist Bioscience Corp (TWST). Click either name above to swap in a different company.
Twist Bioscience Corp is the larger business by last-quarter revenue ($103.7M vs $84.3M, roughly 1.2× LTC PROPERTIES INC). LTC PROPERTIES INC runs the higher net margin — 123.0% vs -29.4%, a 152.4% gap on every dollar of revenue. On growth, LTC PROPERTIES INC posted the faster year-over-year revenue change (60.3% vs 16.9%). LTC PROPERTIES INC produced more free cash flow last quarter ($128.7M vs $-34.8M).
LTC Properties Inc is a U.S.-based real estate investment trust (REIT) that owns, finances, and manages seniors housing and healthcare-related real estate assets. Its core portfolio includes assisted living facilities, skilled nursing properties, memory care centers, and independent living communities for senior care and healthcare service operators.
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
LTC vs TWST — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $84.3M | $103.7M |
| Net Profit | $103.7M | $-30.5M |
| Gross Margin | — | 52.0% |
| Operating Margin | — | -31.7% |
| Net Margin | 123.0% | -29.4% |
| Revenue YoY | 60.3% | 16.9% |
| Net Profit YoY | 429.1% | 3.4% |
| EPS (diluted) | $2.19 | $-0.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $84.3M | $103.7M | ||
| Q3 25 | $69.3M | — | ||
| Q2 25 | $60.2M | — | ||
| Q1 25 | $49.0M | — | ||
| Q4 24 | $52.6M | — | ||
| Q3 24 | $55.8M | — | ||
| Q2 24 | $50.1M | — | ||
| Q1 24 | $51.4M | — |
| Q4 25 | $103.7M | $-30.5M | ||
| Q3 25 | $-20.0M | — | ||
| Q2 25 | $15.1M | — | ||
| Q1 25 | $20.7M | — | ||
| Q4 24 | $19.6M | — | ||
| Q3 24 | $29.4M | — | ||
| Q2 24 | $19.4M | — | ||
| Q1 24 | $24.2M | — |
| Q4 25 | — | 52.0% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | -31.7% | ||
| Q3 25 | 71.9% | — | ||
| Q2 25 | 80.5% | — | ||
| Q1 25 | 37.8% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 95.5% | — | ||
| Q2 24 | 38.0% | — | ||
| Q1 24 | 47.3% | — |
| Q4 25 | 123.0% | -29.4% | ||
| Q3 25 | -28.9% | — | ||
| Q2 25 | 25.1% | — | ||
| Q1 25 | 42.2% | — | ||
| Q4 24 | 37.3% | — | ||
| Q3 24 | 52.6% | — | ||
| Q2 24 | 38.6% | — | ||
| Q1 24 | 47.2% | — |
| Q4 25 | $2.19 | $-0.50 | ||
| Q3 25 | $-0.44 | — | ||
| Q2 25 | $0.32 | — | ||
| Q1 25 | $0.45 | — | ||
| Q4 24 | $0.38 | — | ||
| Q3 24 | $0.66 | — | ||
| Q2 24 | $0.44 | — | ||
| Q1 24 | $0.56 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $14.4M | $197.9M |
| Total DebtLower is stronger | $842.2M | — |
| Stockholders' EquityBook value | $1.1B | $456.1M |
| Total Assets | $2.1B | $638.1M |
| Debt / EquityLower = less leverage | 0.78× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $14.4M | $197.9M | ||
| Q3 25 | $17.9M | — | ||
| Q2 25 | $7.6M | — | ||
| Q1 25 | $23.3M | — | ||
| Q4 24 | $9.4M | — | ||
| Q3 24 | $35.0M | — | ||
| Q2 24 | $6.2M | — | ||
| Q1 24 | $9.0M | — |
| Q4 25 | $842.2M | — | ||
| Q3 25 | $944.5M | — | ||
| Q2 25 | $696.5M | — | ||
| Q1 25 | $682.2M | — | ||
| Q4 24 | $684.6M | — | ||
| Q3 24 | $785.3M | — | ||
| Q2 24 | $861.0M | — | ||
| Q1 24 | $860.2M | — |
| Q4 25 | $1.1B | $456.1M | ||
| Q3 25 | $957.9M | — | ||
| Q2 25 | $957.5M | — | ||
| Q1 25 | $961.9M | — | ||
| Q4 24 | $960.6M | — | ||
| Q3 24 | $947.8M | — | ||
| Q2 24 | $889.1M | — | ||
| Q1 24 | $886.2M | — |
| Q4 25 | $2.1B | $638.1M | ||
| Q3 25 | $2.0B | — | ||
| Q2 25 | $1.8B | — | ||
| Q1 25 | $1.8B | — | ||
| Q4 24 | $1.8B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.9B | — | ||
| Q1 24 | $1.8B | — |
| Q4 25 | 0.78× | — | ||
| Q3 25 | 0.99× | — | ||
| Q2 25 | 0.73× | — | ||
| Q1 25 | 0.71× | — | ||
| Q4 24 | 0.71× | — | ||
| Q3 24 | 0.83× | — | ||
| Q2 24 | 0.97× | — | ||
| Q1 24 | 0.97× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $136.0M | $-24.8M |
| Free Cash FlowOCF − Capex | $128.7M | $-34.8M |
| FCF MarginFCF / Revenue | 152.7% | -33.5% |
| Capex IntensityCapex / Revenue | 8.6% | 9.6% |
| Cash ConversionOCF / Net Profit | 1.31× | — |
| TTM Free Cash FlowTrailing 4 quarters | $220.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $136.0M | $-24.8M | ||
| Q3 25 | $38.4M | — | ||
| Q2 25 | $30.0M | — | ||
| Q1 25 | $29.6M | — | ||
| Q4 24 | $125.9M | — | ||
| Q3 24 | $34.0M | — | ||
| Q2 24 | $37.0M | — | ||
| Q1 24 | $21.1M | — |
| Q4 25 | $128.7M | $-34.8M | ||
| Q3 25 | $34.3M | — | ||
| Q2 25 | $28.9M | — | ||
| Q1 25 | $28.2M | — | ||
| Q4 24 | $112.2M | — | ||
| Q3 24 | $27.7M | — | ||
| Q2 24 | $34.7M | — | ||
| Q1 24 | $19.7M | — |
| Q4 25 | 152.7% | -33.5% | ||
| Q3 25 | 49.4% | — | ||
| Q2 25 | 47.9% | — | ||
| Q1 25 | 57.6% | — | ||
| Q4 24 | 213.4% | — | ||
| Q3 24 | 49.7% | — | ||
| Q2 24 | 69.1% | — | ||
| Q1 24 | 38.4% | — |
| Q4 25 | 8.6% | 9.6% | ||
| Q3 25 | 6.0% | — | ||
| Q2 25 | 1.9% | — | ||
| Q1 25 | 2.7% | — | ||
| Q4 24 | 26.0% | — | ||
| Q3 24 | 11.2% | — | ||
| Q2 24 | 4.6% | — | ||
| Q1 24 | 2.6% | — |
| Q4 25 | 1.31× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 1.99× | — | ||
| Q1 25 | 1.43× | — | ||
| Q4 24 | 6.43× | — | ||
| Q3 24 | 1.16× | — | ||
| Q2 24 | 1.91× | — | ||
| Q1 24 | 0.87× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LTC
| Seniors Housing Operating Portfolio Segment | $72.1M | 86% |
| Other | $12.2M | 14% |
TWST
| Industrial Chemicals | $37.2M | 36% |
| Diagnostics | $35.3M | 34% |
| Food Or Agriculture | $12.8M | 12% |
| Academic Research | $12.2M | 12% |
| Health Care | $6.1M | 6% |
